12.31
-0.70 (-5.38%)
Previous Close | 13.01 |
Open | 13.00 |
Volume | 6,186,403 |
Avg. Volume (3M) | 12,841,320 |
Market Cap | 8,392,207,360 |
Price / Earnings (TTM) | 12.19 |
Price / Earnings (Forward) | 12.44 |
Price / Sales | 1.26 |
Price / Book | 1.34 |
52 Weeks Range | |
Earnings Date | 31 Oct 2025 |
Profit Margin | 10.70% |
Operating Margin (TTM) | 8.21% |
Diluted EPS (TTM) | 1.04 |
Quarterly Revenue Growth (YOY) | -5.90% |
Quarterly Earnings Growth (YOY) | 6.80% |
Total Debt/Equity (MRQ) | 67.34% |
Current Ratio (MRQ) | 1.12 |
Operating Cash Flow (TTM) | 808.50 M |
Levered Free Cash Flow (TTM) | 751.08 M |
Return on Assets (TTM) | 3.53% |
Return on Equity (TTM) | 12.52% |
Market Trend
Short Term | Medium Term | ||
Industry | Medical Instruments & Supplies (US) | Mixed | Bearish |
Medical Instruments & Supplies (Global) | Mixed | Bearish | |
Stock | Avantor, Inc. | Bearish | Bearish |
AIStockmoo Score
Analyst Consensus | -0.5 |
Insider Activity | NA |
Price Volatility | 0.5 |
Technical Moving Averages | -3.5 |
Technical Oscillators | -0.5 |
Average | -1.00 |
Avantor Inc provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company has three geographic segments: the Americas, Europe, and AMEA. The company's product group consists of Equipment & instrumentation, Services & specialty procurement, Proprietary materials & consumables, and Third-party materials & consumables. Materials & consumables include high-purity chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, and education and microbiology and clinical trial kits, peristaltic pumps and fluid handling tips. |
|
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
Investment Style | Mid Core |
% Held by Insiders | 1.35% |
% Held by Institutions | 103.17% |
Ownership
Name | Date | Shares Held |
---|---|---|
New Mountain Capital, L.L.C. | 30 Jun 2025 | 14,000,000 |
Clarkston Capital Partners, Llc | 30 Jun 2025 | 13,982,090 |
Robeco Schweiz Ag | 30 Jun 2025 | 8,727,184 |
52 Weeks Range | ||
Price Target Range | ||
High | 17.00 (RBC Capital, 38.10%) | Buy |
Median | 14.00 (13.73%) | |
Low | 12.00 (Morgan Stanley, -2.52%) | Hold |
12.00 (Stifel, -2.52%) | Hold | |
Average | 14.33 (16.41%) | |
Total | 7 Buy, 2 Hold | |
Avg. Price @ Call | 11.30 |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
Baird | 04 Aug 2025 | 15.00 (21.85%) | Buy | 11.30 |
28 Jul 2025 | 18.00 (46.22%) | Buy | 13.99 | |
Barclays | 04 Aug 2025 | 13.00 (5.61%) | Buy | 11.30 |
Evercore ISI Group | 04 Aug 2025 | 16.00 (29.98%) | Buy | 11.30 |
JP Morgan | 04 Aug 2025 | 14.00 (13.73%) | Buy | 11.30 |
Morgan Stanley | 04 Aug 2025 | 12.00 (-2.52%) | Hold | 11.30 |
RBC Capital | 04 Aug 2025 | 17.00 (38.10%) | Buy | 11.30 |
Raymond James | 04 Aug 2025 | 14.00 (13.73%) | Buy | 11.30 |
Stifel | 04 Aug 2025 | 12.00 (-2.52%) | Hold | 11.30 |
Wells Fargo | 04 Aug 2025 | 16.00 (29.98%) | Buy | 11.30 |
No data within this time range.
Date | Type | Details |
---|---|---|
27 Aug 2025 | Announcement | Bloomberg 500 (B500) Index Adds Sixteen Securities Following Semi-Annual Reconstitution |
11 Aug 2025 | Announcement | Avantor® Reiterates Shareholder Value Creation Focus |
11 Aug 2025 | Announcement | Engine Capital Sends Letter to Avantor’s Board of Directors Regarding Opportunities to Improve Governance and Unlock Shareholder Value |
01 Aug 2025 | Announcement | Avantor® Reports Second Quarter 2025 Results |
21 Jul 2025 | Announcement | Avantor Announces Emmanuel Ligner as Next President and CEO |
27 Jun 2025 | Announcement | Avantor® to Host Second Quarter 2025 Earnings Call on Friday, August 1, 2025 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |